Faizaan Mohammad - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Faizaan Mohammad

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Nature Structural & Molecular Biology|February 28, 2018

Accurate H3K27 methylation can be established de novo by SUZ12-directed PRC2Jonas W Højfeldt, Anne Laugesen, Berthe M Willumsen, et al.

Nature Medicine|March 7, 2017

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomasFaizaan Mohammad, Simon Weissmann, Benjamin Leblanc, et al.

Cancer Research|July 10, 2020

Mutant FOXL2<sup>C134W</sup> Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell TumorsStine E Weis-Banke, Mads Lerdrup, Daniela Kleine-Kohlbrecher, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Nature Structural & Molecular Biology|February 28, 2018

Accurate H3K27 methylation can be established de novo by SUZ12-directed PRC2Jonas W Højfeldt, Anne Laugesen, Berthe M Willumsen, et al.

Nature Medicine|March 7, 2017

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomasFaizaan Mohammad, Simon Weissmann, Benjamin Leblanc, et al.

Cancer Research|July 10, 2020

Mutant FOXL2<sup>C134W</sup> Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell TumorsStine E Weis-Banke, Mads Lerdrup, Daniela Kleine-Kohlbrecher, et al.

Pageof 2